RecruitingNCT03398629

Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies

Diagnosis and Management of Intrauterine Growth Restriction, Structural Anomalies and Chromosomal Anomalies: A Prospective Cohort Study

Sponsor

Guangzhou Women and Children's Medical Center

Enrollment

10,000 participants

Start Date

May 1, 2019

Study Type

OBSERVATIONAL

Conditions

Pregnancy Intrauterine Growth Restriction Fetal Anomaly Chromosomal Anomalies

Summary

The purpose of this prospective cohort study is to build a large platform that includes clinical information (prenatal diagnosis and postnatal follow-up data) and biological specimen banks of fetuses/infants with IUGR or congenital anomalies, which provide vital support and research foundation for accurate diagnosis, precision treatment and meticulous management.

Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with chromosomal anomalies, fetal anomaly, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.